135 related articles for article (PubMed ID: 38933375)
1. Long-term amelioration of an early-onset familial atrial fibrillation model with AAV-mediated in vivo gene therapy.
Hu H; Wang L; Li H; Li H; Chen X; Peng W; Wang J; Zhao Y; Liu M; Li D
Fundam Res; 2022 Nov; 2(6):829-835. PubMed ID: 38933375
[TBL] [Abstract][Full Text] [Related]
2. Metastable Atrial State Underlies the Primary Genetic Substrate for MYL4 Mutation-Associated Atrial Fibrillation.
Ghazizadeh Z; Kiviniemi T; Olafsson S; Plotnick D; Beerens ME; Zhang K; Gillon L; Steinbaugh MJ; Barrera V; Sui SH; Werdich AA; Kapur S; Eranti A; Gunn J; Jalkanen J; Airaksinen J; Kleber AG; Hollmén M; MacRae CA
Circulation; 2020 Jan; 141(4):301-312. PubMed ID: 31735076
[TBL] [Abstract][Full Text] [Related]
3. A frameshift deletion in the sarcomere gene MYL4 causes early-onset familial atrial fibrillation.
Gudbjartsson DF; Holm H; Sulem P; Masson G; Oddsson A; Magnusson OT; Saemundsdottir J; Helgadottir HT; Helgason H; Johannsdottir H; Gretarsdottir S; Gudjonsson SA; Njølstad I; Løchen ML; Baum L; Ma RC; Sigfusson G; Kong A; Thorgeirsson G; Sverrisson JT; Thorsteinsdottir U; Stefansson K; Arnar DO
Eur Heart J; 2017 Jan; 38(1):27-34. PubMed ID: 27742809
[TBL] [Abstract][Full Text] [Related]
4. Dysfunction of Myosin Light-Chain 4 (MYL4) Leads to Heritable Atrial Cardiomyopathy With Electrical, Contractile, and Structural Components: Evidence From Genetically-Engineered Rats.
Peng W; Li M; Li H; Tang K; Zhuang J; Zhang J; Xiao J; Jiang H; Li D; Yu Y; Sham PC; Nattel S; Xu Y
J Am Heart Assoc; 2017 Oct; 6(11):. PubMed ID: 29080865
[TBL] [Abstract][Full Text] [Related]
5. Myosin light-chain 4 gene-transfer attenuates atrial fibrosis while correcting autophagic flux dysregulation.
Zhong Y; Tang K; Nattel S; Zhai M; Gong S; Yu Q; Zeng Y; E G; Maimaitiaili N; Wang J; Xu Y; Peng W; Li H
Redox Biol; 2023 Apr; 60():102606. PubMed ID: 36645977
[TBL] [Abstract][Full Text] [Related]
6. Rs4968309 in Myosin Light Chain 4 (MYL4) Associated With Atrial Fibrillation Onset and Predicts Clinical Outcomes After Catheter Ablation in Atrial Fibrillation Patients Without Structural Heart Disease.
Zhong Y; Tang K; Li H; Zhao D; Kou W; Xu S; Zhang J; Yang H; Li S; Guo R; Peng W; Xu Y
Circ J; 2019 Sep; 83(10):1994-2001. PubMed ID: 31406021
[TBL] [Abstract][Full Text] [Related]
7. A mutation in the atrial-specific myosin light chain gene (MYL4) causes familial atrial fibrillation.
Orr N; Arnaout R; Gula LJ; Spears DA; Leong-Sit P; Li Q; Tarhuni W; Reischauer S; Chauhan VS; Borkovich M; Uppal S; Adler A; Coughlin SR; Stainier DYR; Gollob MH
Nat Commun; 2016 Apr; 7():11303. PubMed ID: 27066836
[TBL] [Abstract][Full Text] [Related]
8. Prevention of Atrial Fibrillation by Using Sarcoplasmic Reticulum Calcium ATPase Pump Overexpression in a Rabbit Model of Rapid Atrial Pacing.
Wang HL; Zhou XH; Li ZQ; Fan P; Zhou QN; Li YD; Hou YM; Tang BP
Med Sci Monit; 2017 Aug; 23():3952-3960. PubMed ID: 28811460
[TBL] [Abstract][Full Text] [Related]
9. Correlation between Serum Myosin Light Chain 4 Levels and Recurrence after Radiofrequency Ablation in Patients with Atrial Fibrillation.
Yu Y; Fang R; Jin H; Wang B; Gao F; He B
Int Heart J; 2023; 64(4):632-640. PubMed ID: 37518344
[TBL] [Abstract][Full Text] [Related]
10. Atrial-Specific Gene Delivery Using an Adeno-Associated Viral Vector.
Ni L; Scott L; Campbell HM; Pan X; Alsina KM; Reynolds J; Philippen LE; Hulsurkar M; Lagor WR; Li N; Wehrens XHT
Circ Res; 2019 Jan; 124(2):256-262. PubMed ID: 30582449
[TBL] [Abstract][Full Text] [Related]
11. Ablation for atrial fibrillation: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2006; 6(7):1-63. PubMed ID: 23074498
[TBL] [Abstract][Full Text] [Related]
12. Relationship between Serum miR-106 and MYL4 Levels and the Prevalence, Risk Stratification, and Prognosis of Atrial Fibrillation.
Liu Y; Zhou H; Tao Y; Xu Z; Lai H
J Immunol Res; 2022; 2022():1069866. PubMed ID: 35874900
[TBL] [Abstract][Full Text] [Related]
13. A KCNQ1 mutation causes a high penetrance for familial atrial fibrillation.
Bartos DC; Anderson JB; Bastiaenen R; Johnson JN; Gollob MH; Tester DJ; Burgess DE; Homfray T; Behr ER; Ackerman MJ; Guicheney P; Delisle BP
J Cardiovasc Electrophysiol; 2013 May; 24(5):562-9. PubMed ID: 23350853
[TBL] [Abstract][Full Text] [Related]
14. IKs Gain- and Loss-of-Function in Early-Onset Lone Atrial Fibrillation.
Steffensen AB; Refsgaard L; Andersen MN; Vallet C; Mujezinovic A; Haunsø S; Svendsen JH; Olesen SP; Olesen MS; Schmitt N
J Cardiovasc Electrophysiol; 2015 Jul; 26(7):715-23. PubMed ID: 25786344
[TBL] [Abstract][Full Text] [Related]
15. Next-generation sequencing of nine atrial fibrillation candidate genes identified novel de novo mutations in patients with extreme trait of atrial fibrillation.
Tsai CT; Hsieh CS; Chang SN; Chuang EY; Juang JM; Lin LY; Lai LP; Hwang JJ; Chiang FT; Lin JL
J Med Genet; 2015 Jan; 52(1):28-36. PubMed ID: 25391453
[TBL] [Abstract][Full Text] [Related]
16. Mutation E169K in junctophilin-2 causes atrial fibrillation due to impaired RyR2 stabilization.
Beavers DL; Wang W; Ather S; Voigt N; Garbino A; Dixit SS; Landstrom AP; Li N; Wang Q; Olivotto I; Dobrev D; Ackerman MJ; Wehrens XHT
J Am Coll Cardiol; 2013 Nov; 62(21):2010-9. PubMed ID: 23973696
[TBL] [Abstract][Full Text] [Related]
17. A novel KCNQ1 missense mutation identified in a patient with juvenile-onset atrial fibrillation causes constitutively open IKs channels.
Hasegawa K; Ohno S; Ashihara T; Itoh H; Ding WG; Toyoda F; Makiyama T; Aoki H; Nakamura Y; Delisle BP; Matsuura H; Horie M
Heart Rhythm; 2014 Jan; 11(1):67-75. PubMed ID: 24096004
[TBL] [Abstract][Full Text] [Related]
18. A Missense Variant in PLEC Increases Risk of Atrial Fibrillation.
Thorolfsdottir RB; Sveinbjornsson G; Sulem P; Helgadottir A; Gretarsdottir S; Benonisdottir S; Magnusdottir A; Davidsson OB; Rajamani S; Roden DM; Darbar D; Pedersen TR; Sabatine MS; Jonsdottir I; Arnar DO; Thorsteinsdottir U; Gudbjartsson DF; Holm H; Stefansson K
J Am Coll Cardiol; 2017 Oct; 70(17):2157-2168. PubMed ID: 29050564
[TBL] [Abstract][Full Text] [Related]
19. TBX5 mutations contribute to early-onset atrial fibrillation in Chinese and Caucasians.
Ma JF; Yang F; Mahida SN; Zhao L; Chen X; Zhang ML; Sun Z; Yao Y; Zhang YX; Zheng GY; Dong J; Feng MJ; Zhang R; Sun J; Li S; Wang QS; Cao H; Benjamin EJ; Ellinor PT; Li YG; Tian XL
Cardiovasc Res; 2016 Mar; 109(3):442-50. PubMed ID: 26762269
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic Prospects of Gene Therapy for Atrial Fibrillation.
Farraha M; Chong JJ; Kizana E
Heart Lung Circ; 2016 Aug; 25(8):808-13. PubMed ID: 27262391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
